Christina Rossi insider trades: Blueprint Medicines (BPMC) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Christina reports to the SEC
Open-market buys and sales
17 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 3, 2025 | BPMC | ↓ Sell | 1,172 | $128.25 | $150K | Direct | Jul 8, 2025 (5d) |
| May 19, 2025 | BPMC | ↓ Sell | 2,274 | $100.51 | $229K | Direct | May 21, 2025 (2d) |
| May 5, 2025 | BPMC | ↓ Sell | 2,274 | $101.75 | $231K | Direct | May 7, 2025 (2d) |
| Mar 24, 2025 | BPMC | ↓ Sell | 2,274 | $95.02 | $216K | Direct | Mar 26, 2025 (2d) |
| Mar 5, 2025 | BPMC | ↓ Sell | 6,495 | $88.80 | $577K | Direct | Mar 7, 2025 (2d) |
| Feb 20, 2025 | BPMC | ↓ Sell | 2,274 | $95.14 | $216K | Direct | Feb 24, 2025 (4d) |
| Jan 21, 2025 | BPMC | ↓ Sell | 2,274 | $110.14 | $250K | Direct | Jan 23, 2025 (2d) |
| Dec 18, 2024 | BPMC | ↓ Sell | 2,274 | $95.91 | $218K | Direct | Dec 20, 2024 (2d) |
| Nov 27, 2024 | BPMC | ↓ Sell | 2,274 | $95.10 | $216K | Direct | Dec 2, 2024 (5d) |
| Mar 7, 2024 | BPMC | ↓ Sell | 6,070 | $90.69 | $550K | Direct | Mar 11, 2024 (4d) |
| Mar 6, 2023 | BPMC | ↓ Sell | 3,059 | $45.67 | $140K | Direct | Mar 8, 2023 (2d) |
| Nov 3, 2022 | BPMC | ↓ Sell | 533 | $45.24 | $24K | Direct | Nov 7, 2022 (4d) |
| Mar 7, 2022 | BPMC | ↓ Sell | 2,244 | $58.37 | $131K | Direct | Mar 8, 2022 (1d) |
| Nov 3, 2021 | BPMC | ↓ Sell | 511 | $110.85 | $57K | Direct | Mar 23, 2022 (140d) |
| Mar 4, 2021 | BPMC | ↓ Sell | 1,359 | $86.77 | $118K | Direct | Mar 5, 2021 (1d) |
| Nov 3, 2020 | BPMC | ↓ Sell | 345 | $99.69 | $34K | Direct | Nov 5, 2020 (2d) |
| Mar 9, 2020 | BPMC | ↓ Sell | 135 | $51.96 | $7K | Direct | Mar 11, 2020 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Christina Rossi's insider trades
Christina Rossi is Chief Operating Officer at Blueprint Medicines (BPMC). Since Mar 9, 2020, Christina has reported no open-market purchases and 17 sales worth $3.4M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (15 filings), other transactions (1 filing), shares returned to the company (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BPMC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.